PTGER3 and breast cancer: Former study outcomes suggested that the EP3 receptor plays a role in angiogenesis and EP3 agonists stimulate cell migration dose dependently in Chinese hamster ovary cells [33]; however which role EP3 specifically plays in breast cancer has yet to be determined.